Experience

Access Accelerated
• Switzerland
• Civic and Social Organizations
• 1 - 100 Employee
• Director

  • Mar 2022 - Present

University of Geneva
• Switzerland
• Research Services
• 700 & Above Employee
• Lecturer, Health Economics and Politics

  • Sep 2005 - Present


Sanofi Group

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• VP, Head Global Public Affairs, General Medicines & Emerging Markets

  • Nov 2016 - Dec 2021

  Martin is in charge of the public affairs strategy for the Sanofi’s Global Business Unit “General Medicines & Emerging Markets”, also responsible for the relations with the World Health Organisation. He is leading Sanofi strategy on Non-Communicable Diseases. Prior to this, he was Vice President International Institutions, Sanofi Group, and Public Affairs & Market Access Director, Sanofi-Aventis Switzerland.Before joining the pharmaceutical industry, he led research in Health System Science at the Laboratory of Applied Economics, Geneva University. He is still a lecturer at the Pharmacy School, teaching Health Economics and Politics. Engaged for the global access to quality healthcare, Martin is chairing the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) work stream on Counterfeit Medicines. He is also co-chair of the NCD Alliance Supporters Group and is a member of the Steering Committee of the NCD Access Accelerated Initiative.Martin is an Economic and Social Scientist by training, with specialisation in Pharmacoeconomics.

• Vice President International Institutions

  • May 2010 - Oct 2016



sanofi-aventis (suisse) sa

• Switzerland
• Retail
• 1 - 100 Employee

• Public Affairs and Market Access Director

  • Oct 2007 - Apr 2010

• Public Affairs Deputy

  • Jan 2006 - Sep 2007